(E)-3-(pyridin-4-ylmethylene)indolin-2-one | 128564-78-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: (E)-3-(pyridin-4-ylmethylene)indolin-2-one
• 英文别名: 3-(4-pyridinylmethylidene)-2-oxindole；(3E)-3-(pyridin-4-ylmethylidene)-1H-indol-2-one
• CAS: 128564-78-3
• 化学式: C₁₄H₁₀N₂O
• 分子量: 222.246
• InChiKey: YJIPMQPTUPEVAU-FMIVXFBMSA-N

物化性质

• 熔点：
  222-223 °C(Solv: ethanol (64-17-5))
• 沸点：
  468.2±45.0 °C(Predicted)
• 密度：
  1.291±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3,4-二氯氯苄 、 (E)-3-(pyridin-4-ylmethylene)indolin-2-one 以 乙腈 为溶剂， 以90%的产率得到(E)-1-(3,4-dichlorobenzyl)-4-((2-oxoindolin-3-ylidene)methyl)pyridinium chloride
  参考文献：
  名称：

  Indolinone-based acetylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling

  摘要：

  A series of indolinone-based compounds bearing benzylpyridinium moiety was designed as dual-binding inhibitors of acetylcholinesterase (AChE). The target compounds 3a-u were synthesized by condensation of oxindole and pyridin-4-carbalehyde, and subsequent N-benzylation. The anti-cholinesterase activity evaluation of synthesized compounds revealed that most of them had very potent inhibitory activity against AChE, superior to standard drug donepezil. Particularly, 2-chlorobenzyl derivative 3c was the most potent compound against AChE with IC50 value of 0.44 nM, being 32-fold more potent than donepezil. Also, most of compounds were more potent than standard drug donepezil against butyrylcholinesterase (BuChE). Docking study revealed that the hydrophobic aromatic part (indoline) of representative compound 3c binds to the PAS and the N-benzylpyridinium residue binds to the CAS of AChE.

  DOI：

  10.1016/j.ejmech.2014.01.017
• 作为产物：
  描述：

  4-甲基吡啶 在 对甲苯磺酸 作用下， 以 苯 为溶剂， 反应 27.0h， 生成 (E)-3-(pyridin-4-ylmethylene)indolin-2-one
  参考文献：
  名称：

  具有基本功能的吲哚的化学，第 31 部分 Spiro [cyclopropane-1,3 ' [3H] indole] -2 ' (1'H) -ones 的合成具有抗缺氧作用

  摘要：

  羟基吲哚酮 (1-6, 15-16) 通过用 4-甲苯磺酸脱水转化为靛红 (7,9-13, 17-19)。在少数情况下也分离出二聚体型化合物 (14, 20)。将获得的靛红转化为 3-螺-环丙烷-羟吲哚（21-32）与二甲基氧锍甲基化物。化合物 22 显示出对低压缺氧和三乙基锡诱导的脑水肿的保护作用。

  DOI：

  10.1002/ardp.19963291206

文献信息

• Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors
  作者：Natalia A. Lozinskaya、Denis A. Babkov、Ekaterina V. Zaryanova、Elena N. Bezsonova、Alexander M. Efremov、Michael D. Tsymlyakov、Lada V. Anikina、Olga Yu. Zakharyascheva、Alexander V. Borisov、Valentina N. Perfilova、Ivan N. Tyurenkov、Marina V. Proskurnina、Alexander A. Spasov

  DOI：10.1016/j.bmc.2019.03.028

  日期：2019.5

  Glycogen synthase kinase 3β (GSK-3β) is a widely investigated molecular target for numerous diseases including Alzheimer's disease, cancer, and diabetes mellitus. Inhibition of GSK-3β activity has become an attractive approach for treatment of diabetes and cancer. We report the discovery of novel GSK-3β inhibitors of 3-arylidene-2-oxindole scaffold with promising activity. The most potent compound

  糖原合酶激酶3β（GSK-3β）是许多疾病的分子靶标，包括阿尔茨海默氏病，癌症和糖尿病。抑制GSK-3β活性已成为治疗糖尿病和癌症的一种有吸引力的方法。我们报告发现具有前途活性的3-亚芳基-2-氧吲哚支架的新型GSK-3β抑制剂。最有效的化合物3a抑制GSK-3β，IC50为4.19 nM。在基于细胞的测定中，3a在10 µM时无明显白细胞毒性，对A549细胞具有中等程度的细胞毒性。化合物3a在肥胖的链脲佐菌素治疗的大鼠中表现出很高的抗糖尿病功效，以50 mg / kg体重的剂量改善了葡萄糖耐量，因此代表了进一步优化的有趣线索。
• Selective C3-alkenylation of oxindole with aldehydes using heterogeneous CeO2 catalyst
  作者：Md. Nurnobi Rashed、Abeda Sultana Touchy、Chandan Chaudhari、Jaewan Jeon、S.M.A. Hakim Siddiki、Takashi Toyao、Ken-ichi Shimizu

  DOI：10.1016/s1872-2067(19)63515-1

  日期：2020.6

  reusable catalyst for the C3-selective alkenylation of oxindole with aldehydes under solvent-free conditions. This catalytic method is generally applicable to different aromatic and aliphatic aldehydes, giving 3-alkyledene-oxindoles in high yields (87%–99%) and high stereoselectivities (79%–93% to E-isomers). This is the first example of the catalytic synthesis of 3-alkenyl-oxindoles from oxindole and

  摘要 我们在本文中报道，市售的 CeO2 是一种活性且可重复使用的催化剂，可用于在无溶剂条件下将 oxindole 与醛进行 C3 选择性烯基化。这种催化方法通常适用于不同的芳香族和脂肪族醛，以高产率（87%–99%）和高立体选择性（79%–93% 的 E-异构体）得到 3-亚烷基-羟吲哚。这是从羟吲哚和各种脂肪醛催化合成 3-烯基-羟吲哚的第一个例子。通过原位 IR 研究了 CeO2 上的路易斯酸位点与苯甲醛之间的路易斯酸碱相互作用。使用不同尺寸的 CeO2 催化剂的构效关系研究表明，无缺陷的 CeO2 表面是该反应的活性位点。
• Functionalized 3-benzylidene-indolin-2-ones: Inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity
  作者：Wei Zhang、Mei-Lin Go

  DOI：10.1016/j.bmc.2008.12.052

  日期：2009.3

  Functionalized benzylidene-indolin-2-ones are widely associated with antiproliferative activity. The scaffold is not normally associated with chemoprevention in spite of the presence of a nitrogen-linked Michael acceptor moiety that may predispose members to induction of NQO1, a widely used biomarker of chemopreventive potential. To investigate this possibility, we have synthesized and evaluated a series of functionalized 3-benzylidene-indolin-2-ones for induction of NQO1 in murine Hepa1c1c7 cells as well as antiproliferative activity against two human cancer cell lines (MCF-7, HCT116). The benzylideneindolinones were found to be good inducers of NQO1 activity, with 85% of test compounds able to increase basal NQO1 activity by more than twofold at concentrations of <= 10 mu M. By contrast, fewer compounds (11%) tested at the same concentration were able to reduce cell viability by more than 50%. Structure activity relationships showed that the nitrogen linked Michael acceptor moiety was an essential requirement for both activities. This common feature notwithstanding, substitution of the 3-benzylidene-indolin-2-one core structure affected NQO1 induction and antiproliferative activities in dissimilar ways, underscoring different structural requirements for these two activities. Nonetheless, promising compounds ( 10, 42, 45-48) were identified that combine selective induction of NQO1 with potent antiproliferative activity. A potential advantage of such agents would be the ability to provide added protection to normal cells by the up-regulation of NQO1 and other phase II enzymes while simultaneously targeting neoplastic cells. (C) 2008 Elsevier Ltd. All rights reserved.
• Chemistry of Indoles Carrying a Basic Function, Part 31 Synthesis of Spiro[cyclopropane-1,3′[3H]indol]-2′(1′H)-ones with Antihypoxic Effects
  作者：István Moldvai、Eszter Gács-Baitz、Mihály Balázs、Mária Incze、Csaba Szántay

  DOI：10.1002/ardp.19963291206

  日期：——

  into isatinylidenes (7,9–13, 17–19) by dehydration with 4‐toluenesulfonic acid. The dimer‐type compounds (14, 20) were also isolated in a few cases. The obtained isatinylidenes were transformed into 3‐spiro‐cyclopropane‐oxindoles (21–32) with dimethyloxosulfonium methylide. Compound 22 shows protective effects against hypobaric hypoxia and triethyltin induced brain edema.

  羟基吲哚酮 (1-6, 15-16) 通过用 4-甲苯磺酸脱水转化为靛红 (7,9-13, 17-19)。在少数情况下也分离出二聚体型化合物 (14, 20)。将获得的靛红转化为 3-螺-环丙烷-羟吲哚（21-32）与二甲基氧锍甲基化物。化合物 22 显示出对低压缺氧和三乙基锡诱导的脑水肿的保护作用。
• Indolinone-based acetylcholinesterase inhibitors: Synthesis, biological activity and molecular modeling
  作者：Hamidreza Akrami、Bibi Fatemeh Mirjalili、Mehdi Khoobi、Hamid Nadri、Alireza Moradi、Amirhossein Sakhteman、Saeed Emami、Alireza Foroumadi、Abbas Shafiee

  DOI：10.1016/j.ejmech.2014.01.017

  日期：2014.9

  A series of indolinone-based compounds bearing benzylpyridinium moiety was designed as dual-binding inhibitors of acetylcholinesterase (AChE). The target compounds 3a-u were synthesized by condensation of oxindole and pyridin-4-carbalehyde, and subsequent N-benzylation. The anti-cholinesterase activity evaluation of synthesized compounds revealed that most of them had very potent inhibitory activity against AChE, superior to standard drug donepezil. Particularly, 2-chlorobenzyl derivative 3c was the most potent compound against AChE with IC50 value of 0.44 nM, being 32-fold more potent than donepezil. Also, most of compounds were more potent than standard drug donepezil against butyrylcholinesterase (BuChE). Docking study revealed that the hydrophobic aromatic part (indoline) of representative compound 3c binds to the PAS and the N-benzylpyridinium residue binds to the CAS of AChE.